- Report
- July 2024
- 316 Pages
Global
From €4515EUR$4,950USD£3,806GBP
- Database
- October 2024
Global
€2800EUR$3,289USD£2,443GBP
- Database
- September 2024
Global
€1800EUR$2,114USD£1,570GBP
- Report
- November 2024
- 223 Pages
Global
From €5062EUR$5,550USD£4,267GBP
- Report
- June 2024
- 220 Pages
Global
From €5062EUR$5,550USD£4,267GBP
- Report
- May 2025
- 1200 Pages
Global
From €5473EUR$6,000USD£4,613GBP
- Report
- March 2025
- 150 Pages
Global
From €2736EUR$3,000USD£2,306GBP
- Report
- October 2024
- 180 Pages
Global
From €2189EUR$2,400USD£1,845GBP
- Report
- September 2024
- 210 Pages
Global
From €2189EUR$2,400USD£1,845GBP
- Report
- August 2024
- 195 Pages
Global
From €2189EUR$2,400USD£1,845GBP
- Report
- May 2025
- 188 Pages
Global
From €2969EUR$3,255USD£2,503GBP
€4241EUR$4,650USD£3,575GBP
- Report
- April 2025
- 164 Pages
Global
From €2969EUR$3,255USD£2,503GBP
€4241EUR$4,650USD£3,575GBP
- Report
- December 2024
- 125 Pages
Global
From €2969EUR$3,255USD£2,503GBP
€4241EUR$4,650USD£3,575GBP
- Report
- November 2024
- 173 Pages
Global
From €2969EUR$3,255USD£2,503GBP
€4241EUR$4,650USD£3,575GBP
- Report
- July 2024
- 133 Pages
Global
From €2969EUR$3,255USD£2,503GBP
€4241EUR$4,650USD£3,575GBP
- Report
- February 2025
- 200 Pages
Global
From €4095EUR$4,490USD£3,452GBP
- Report
- February 2025
- 274 Pages
Global
From €4515EUR$4,950USD£3,806GBP
- Report
- October 2024
- 298 Pages
Global
From €4515EUR$4,950USD£3,806GBP
- Report
- May 2025
- 100 Pages
Global
From €4469EUR$4,900USD£3,767GBP
- Report
- May 2025
- 100 Pages
Global
From €4469EUR$4,900USD£3,767GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more